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Introduction {#sec1}
============

MicroRNAs (miRNAs) are small, non-coding RNAs that negatively regulate the stability and translation of protein-coding transcripts through partial complementarity with their 3′ UTRs ([@bib17]). There have been reports that miRNAs affect histone modifications or DNA methylation in mammalian cells ([@bib19], [@bib39], [@bib4], [@bib31], [@bib14]), although the mechanisms are often indirect. For example, miRNAs post-transcriptionally control negative regulators of DNA methyltransferases in mouse ESCs ([@bib39], [@bib4], [@bib31]).

In mouse ESCs a set of developmental regulator genes is characterized by the simultaneous presence of activating and repressive histone modifications ([@bib2], [@bib5]). This bivalent state is resolved during ESC differentiation ([@bib29]), suggesting that bivalency keeps genes in a poised state to enable rapid activation or stable silencing upon differentiation ([@bib35], [@bib41]). Bivalent genes are prematurely expressed in ESCs that lack the PRC2 components EED ([@bib2], [@bib6]) or SUZ12 ([@bib33]). PRC2-deficient ESCs remain viable and can self-renew ([@bib34], [@bib9], [@bib37]) but show reduced developmental potential ([@bib34], [@bib9], [@bib37]), and PRC2 mutations are lethal during post-implantation in vivo ([@bib13], [@bib32], [@bib33]). Hence, polycomb group (PcG) repression of bivalent genes may safeguard the pluripotent state and the ability of ESCs to differentiate.

miRNAs affect key features of ESCs, including their characteristic cell-cycle behavior ([@bib42]). miRNAs are critical for ESC pluripotency and differentiation ([@bib30], [@bib1]), and somatic miRNAs facilitate differentiation by terminating the expression of pluripotency factors such as Nanog ([@bib28]). Although much is known about ESC miRNAs, their impact on the regulation of bivalent genes has not been systematically investigated. To address this point we have analyzed the distribution of PRC2 core components and the regulation of bivalent genes in ESCs deficient in the RNase III enzyme DICER, which is required for the biogenesis of most miRNAs ([@bib17]). We find that miRNAs are required for the binding of EZH2 and SUZ12 at many bivalent promoters, and therefore for the maintenance of the bivalent state. These data define an unexpected role for miRNAs in maintaining the bivalent state of developmental regulator genes in mouse ESCs.

Results and Discussion {#sec2}
======================

Previously characterized *Dicer*-deficient ESCs ([@bib31]) were adapted to growth in feeder-free culture with inhibitors of MEK and GSK3β (see [Experimental Procedures](#sec3){ref-type="sec"}). We mapped the distribution of EZH2 by chromatin immunoprecipitation and high-throughput sequencing (ChIP-seq). Control ESCs retained EZH2 promoter binding at 2,110 bivalent genes ([@bib21]) in control ESCs under 2i/LIF culture conditions. Loss of DICER resulted in reduced EZH2 occupancy of bivalent gene promoters ([Figure 1](#fig1){ref-type="fig"}A, left). The number of bivalent promoters was reduced to 1,033, reflecting the loss of EZH2 binding to 1,077 (or 51%) of formerly bivalent genes ([Figure 1](#fig1){ref-type="fig"}A, right) as illustrated for the *Pax6* promoter ([Figure 1](#fig1){ref-type="fig"}B).

Loss of EZH2 was confirmed by ChIP-PCR ([Figure 1](#fig1){ref-type="fig"}C, top). At the sites we tested, the H3K27me3 chromatin mark deposited by PRC2 was reduced ([Figure 1](#fig1){ref-type="fig"}C, middle). As expected ([@bib26]), the promoter mark H3K4me3 was unaffected ([Figure 1](#fig1){ref-type="fig"}C, bottom). To explore the kinetics of EZH2 loss from bivalent promoters, we induced the deletion of *Dicer* by treatment of ERt2Cre *Dicer*^lox/lox^ ESCs with 4-hydroxytamoxifen (4-OHT). *Dicer* mRNA expression declined within 4 days of ERt2Cre induction, followed by the reduced expression of the miRNAs miR-291a-3p and miR-92 ([Figure 1](#fig1){ref-type="fig"}D). EZH2 occupancy of formerly bivalent promoters was reduced within 8 days ([Figure 1](#fig1){ref-type="fig"}E), indicating that EZH2 binding closely follows the reduced expression of miRNAs.

qRT-PCR showed that the expression of the PRC2 core components *Ezh2*, *Suz12*, and *Eed* was not reduced upon *Dicer* deletion ([Figure 2](#fig2){ref-type="fig"}A). Similarly immunoblotting showed no reduction of EZH2, SUZ12, or JARID2 proteins or global H3K4me3 or H3K27me3 ([Figure 2](#fig2){ref-type="fig"}B). Cellular fractionation experiments confirmed that total and chromatin-associated EZH2 protein remained unchanged ([Figure 2](#fig2){ref-type="fig"}C), suggesting selectively reduced binding of EZH2 at the promoters of bivalent genes.

Exclusion of PcG from CpG-methylated regions may focus PcG binding to sites of low CpG methylation, namely CpG islands and CG-rich promoter regions, to facilitate the formation of bivalent domains ([@bib21], [@bib23], [@bib7]). Global DNA methylation levels are reduced in most *Dicer*-deficient ESC lines ([@bib39], [@bib4], [@bib31], [@bib15]) and DNA hypomethylation is linked to PcG redistribution in DNA methyltransferase (Dnmt)-deficient ESCs ([@bib23], [@bib7], [@bib11]). PRDM14 controls *Dnmt3b* expression ([@bib24]) and is upregulated under 2i conditions ([@bib43]), but *Prdm14* mRNA did not further increase in *Dicer*-deficient ESCs (log~2~ fold change −0.36, adjusted p = 0.446). Nevertheless, there were differences in *Dnmt* mRNA ([Figure S1](#mmc1){ref-type="supplementary-material"}A) and DNMT protein ([Figure S1](#mmc1){ref-type="supplementary-material"}B) expression between control and *Dicer*-deficient ESC under 2i/LIF culture conditions ([Figure S1](#mmc1){ref-type="supplementary-material"}A). We therefore used high-performance liquid chromatography to directly monitor the fraction of methylated cytosine residues in response to *Dicer* deletion. Treatment of ERt2Cre *Dicer*^*l*ox/lox^ ESCs with 4-OHT did not affect the fraction of methylated cytosines ([Figure 2](#fig2){ref-type="fig"}D) even though miRNAs were efficiently depleted ([Figure 1](#fig1){ref-type="fig"}D) and EZH2 occupancy was reduced at bivalent promoters ([Figures 1](#fig1){ref-type="fig"}A--1D). Hence, the observed loss of bivalency was not due to globally reduced DNA methylation. Consistent with these data, ChIP-seq and ChIP-PCR analysis showed no substantial redistribution of EZH2 to repeat regions or to other genomic regions that had been reported to gain PRC2 binding in DNMT-deficient ESCs ([Figures S1](#mmc1){ref-type="supplementary-material"}C--S1F).

We explored other potential mechanisms for the observed redistribution of PcG proteins in *Dicer*-deficient ESCs. First, although ERK2 is required for PRC2 occupancy and poised RNA polymerase at developmental genes ([@bib40]), immunoblotting showed no significant differences in ERK1 and -2 protein expression between control and *Dicer*-deficient ESCs ([Figure S1](#mmc1){ref-type="supplementary-material"}G). Second, NUP153 promotes PcG binding to developmentally regulated genes in ESCs ([@bib16]), but our microarray and proteomics data show robust expression of *Nup153* mRNA and NUP153 protein in both control and *Dicer*-deficient ESCs, without any indication of reduced expression in *Dicer*-deficient ESCs ([GSE60161](ncbi-geo:GSE60161){#intref0010}). Finally, PRC2 occupancy may reflect, rather than cause transcriptional repression ([@bib36]). Eviction of PRC2 by transcription could account for the loss of EZH2 from some but not all of the formerly bivalent promoters in *Dicer*-deficient ESCs, since not all formerly bivalent genes showed increased expression of primary transcripts (see below).

We profiled gene expression in control and *Dicer*-deficient ESCs and identified sequence motif enrichment in 3′ UTRs using miReduce. Highly enriched sequence motifs corresponded to binding sites for the ESC miRNAs miR-290--295 and miR-302, as well as miR-17-92 ([Figure 3](#fig3){ref-type="fig"}A). The miR-290--295 cluster is the most highly expressed miRNA population in ESCs ([@bib44]), and miR-290-3p, miR-291a-3p, miR-291b-3p, miR-292-3p, miR-294, and miR-295 contain the hexamer seed AAGUGC, which is shared by the miR-302 cluster. The miR-17-92 family contains the shifted seed AAAGUG and likely shares targets with miR-290--295 and miR-302 ([@bib22], [@bib10], [@bib3]). As expected, transcripts with 3′ UTR motifs for these abundant miRNAs were significantly upregulated in *Dicer*-deficient ESCs ([Figure 3](#fig3){ref-type="fig"}A). In addition, miReduce identified 3′ UTR motifs that matched binding preferences of RNA binding proteins ([Figure S2](#mmc1){ref-type="supplementary-material"}A). We found the 3′ UTRs of bivalent genes enriched for miRNA motifs (p \< 10^−15^, odds ratio = 2.91), including miR-290 (p = 1.17 × 10^−6^, odds ratio = 2.00) and miR-302 (p = 1.1 × 10^−6^, odds ratio = 1.95) ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Similar enrichment (p \< 2.2 × 10^−16^, odds ratio = 2.22) was observed for an independently defined set of bivalent genes ([@bib29]) and for the 2,110 bivalent genes that were bound by the EZH2 in our ESCs (p \< 2.2 × 10^−16^, odds ratio = 3.18 for any miRNA motif; p \< 2.2 × 10^−16^, odds ratio = 3.95 for miR-290; and p \< 10^−10^, odds ratio = 4.32 for miR-302). The genomic basis for the increased occurrence of miRNA motifs was a greater than average 3′ UTR length, rather than a higher density of miRNA motifs in the 3′ UTRs of bivalent genes ([Figure S2](#mmc1){ref-type="supplementary-material"}B).

Gene set enrichment analysis (GSEA) of developmentally regulated genes showed that transcripts from bivalent genes were preferentially upregulated in *Dicer*-deficient ESCs, comparable with a set of Targetscan-predicted target genes of miR-290--295 ([Figure 3](#fig3){ref-type="fig"}B). Eight sets of developmental genes were used for comparison, and only two showed false discovery rates below 25% ([Figure 3](#fig3){ref-type="fig"}C, top). Each gene set contained a subset of bivalent genes, and separating bivalent from non-bivalent developmentally regulated genes showed significantly stronger upregulation of the bivalent subset ([Figure 3](#fig3){ref-type="fig"}C, bottom). The deregulated expression of bivalent genes was extensively validated by qRT-PCR ([Figure S2](#mmc1){ref-type="supplementary-material"}C). To determine whether the deregulated expression of bivalent genes was due to the loss of miRNAs or other aspects of *Dicer*-deficiency, we examined gene expression in *Dicer*-deficient ESCs that had been reconstituted with miR-290 ([@bib39]). miR-290 reconstitution significantly reduced the expression of bivalent genes ([Figure S3](#mmc1){ref-type="supplementary-material"}A). qRT-PCR of *Dicer*-deficient ESCs reconstituted with miR-291a-3p in independent experiments confirmed this result ([Figure S3](#mmc1){ref-type="supplementary-material"}B).

We employed RT-PCR primers specific for intronic sequences to assess the abundance of unspliced (primary) as well as spliced (mature) transcripts (see [Figure 3](#fig3){ref-type="fig"}D). In these experiments we followed the kinetics of transcript expression during the 4-OHT-induced deletion of *Dicer* in ERt2Cre *Dicer*^lox/lox^ ESCs (see [Figure 1](#fig1){ref-type="fig"}D). Some bivalent genes showed selective upregulation of mature transcripts with no (e.g., *Dock2*) or little (e.g., *Cacna1a*) increase in primary transcript expression in *Dicer*-deficient ESCs (blue bars in [Figure 3](#fig3){ref-type="fig"}E). Others, including *Nr2f2*, showed significant upregulation of primary transcripts (blue bars in [Figure 3](#fig3){ref-type="fig"}E). Primary (blue bars in [Figure 3](#fig3){ref-type="fig"}E) and mature transcripts (red bars in [Figure 3](#fig3){ref-type="fig"}E) were deregulated with similar kinetics during the course of *Dicer* deletion ([Figure 3](#fig3){ref-type="fig"}E, data for EtOH-treated control cells are shown in black). There was no clear temporal dissociation between the deregulation of primary and mature transcripts. As miRNAs are thought to act mainly on mature, cytoplasmic transcripts in mammalian cells, the abundance of primary---predominantly nuclear---transcripts can be an indicator of transcriptional activity ([@bib12]). To discover whether miRNAs were directly involved in the regulation of primary transcripts, we transfected wild-type ESCs with locked nucleic acid (LNA) inhibitors of the miR-290--295 family. The LNA-mediated inhibition of miR-290--295 in wild-type ESCs recapitulated the deregulated expression of primary and mature bivalent gene transcripts ([Figure S3](#mmc1){ref-type="supplementary-material"}C).

To define the relationship between EZH2 redistribution and gene expression, we integrated gene-expression and ChIP-seq data. The loss of EZH2 from promoters correlated with an increase in gene expression (p \< 10^−8^). This correlation was particularly strong for bivalent genes (p \< 10^−11^; [Figure 3](#fig3){ref-type="fig"}F).

SILAC-based quantitative proteomics studies were performed to address whether the increased expression of transcripts translated into altered protein expression. Control ESC extracts labeled with "heavy" amino acids were added 1:1 to either control or *Dicer*-deficient ESC extracts. We reliably quantified 3,431 protein groups in both control and *Dicer*-deficient ESCs ([Figure 3](#fig3){ref-type="fig"}G). Of these, 169 (4.9%) were significantly upregulated and 95 (2.8%) were significantly downregulated in *Dicer*-deficient ESCs ([Figure 3](#fig3){ref-type="fig"}G, left). Of 62 proteins encoded by bivalent genes 14 (23%) were upregulated, a much greater fraction than the 4.9% observed genome-wide ([Figure 3](#fig3){ref-type="fig"}G, right). Proteins encoded by two bivalent genes (3%) were downregulated in *Dicer*-deficient ESCs ([Figure 3](#fig3){ref-type="fig"}G, right). Hence, proteins encoded by bivalent genes were preferentially upregulated in *Dicer*-deficient ESCs (odds ratio = 3.93).

To explore whether the impact of DICER on bivalency extends to serum + LIF culture conditions, we analyzed ChIP-seq data for the PRC2 core component SUZ12 ([@bib20]). Similarly to *Dicer* deletion under semi-2i conditions, 968 (46.7%) of 2,074 bivalent genes showed reduced SUZ12 binding in *Dicer*-deficient ESCs in serum + LIF ([Figure 4](#fig4){ref-type="fig"}A). Hence, DICER is required for the maintenance of bivalency in ESCs in serum + LIF as well as in semi-2i conditions.

To address whether the bivalent state requires miRNAs or other *Dicer*-dependent functions, we reconstituted *Dicer*-deficient ESCs with miR-294, a member of the miR-290--295 miRNA family. ChIP-PCR showed that EZH2 binding was restored 48 hr later at the *Gata3*, *Pax6*, and *Nr2f2* promoters ([Figure 4](#fig4){ref-type="fig"}B). Thus, reconstitution of *Dicer*-deficient ESCs with a member of the 290--295 miRNA family was sufficient to rescue PRC2 occupancy of at least a subset of loci that lost the bivalent state in *Dicer*-deficient ESCs.

The expression of bivalent genes is regulated at multiple levels ([@bib8], [@bib25], [@bib38], [@bib18]). We have shown that transcripts from bivalent genes are preferentially targeted by miRNAs because their 3′ UTRs contain significantly more miRNA binding sites. The pluripotency-associated transcription factors OCT4, SOX2, and NANOG control miRNA expression in ESCs ([@bib27]), linking the regulation of bivalent genes by ESC miRNAs to the ESC core regulatory network ([Figure S4](#mmc1){ref-type="supplementary-material"}). An unexpected finding of our study is that miRNAs are required for the recruitment of PRC2 components to bivalent genes, and thereby the state of bivalency itself.

Experimental Procedures {#sec3}
=======================

*Dicer*^lox/lox^ ERT2Cre mouse ESCs ([@bib31]) were adapted to feeder-free conditions on gelatin-coated plates (0.1%) in 50% knockout DMEM, 10% fetal calf serum, and 50% neurobasal DMEM/F12, 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μM β-mercaptoethanol, 0.5 mM non-essential amino acids, 0.5% N2 supplement, 1% (v/v) B27 supplement, 1 μM PD032590, and 3 μM CHIR99021 (Stemgent) as described by [@bib43]. For the conditional deletion of *Dicer*, *Dicer*^lox/lox^ ERt2Cre ESCs were treated with 80 nM 4-OHT. To block miRNA function, we transfected ESCs with LNA inhibitors (500 nM; Exiqon) or negative control oligo (\#199004-00, 500 nM) using Lipofectamine 2000 and assayed them 24 hr later. To mimic mRNA function, we transfected ESCs with miR-291a-3p mimic (C-310470-05, 100 nM) or control (CN-001000-01, 100 nM) oligos (Dharmacon) using DharmFECT Reagent \#1 and assayed them 24 hr later. For rescue experiments, ESCs were transfected with miR-294-3p mimic (C-310474-03-0002, 100 nM, Dharmacon) using Lipofectamine 2000 and assayed 48 hr later. Details of materials and methods for gene expression, western blotting, and proteomics are given in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Accession Numbers {#app1}
=================

The accession number for the microarray and EZH2 ChIP-seq data reported in this paper is GEO: [GSE60161](ncbi-geo:GSE60161){#intref0015}, and the proteomics data are at ProteomeXchange ([http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=adqpgoaqpnehpwj&acc=GSE60161](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=adqpgoaqpnehpwj%26acc=GSE60161){#intref0020}).
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![DICER Maintains the Association of the Core PRC2 Component EZH2 with Many Bivalent Genes in ESCs\
(A) EZH2 occupancy at transcriptional start sites of bivalent genes and numbers of EZH2-peaked bivalent genes that were retained (gray) or lost (orange) in *Dicer-*deficient ESCs. See [Figure 4](#fig4){ref-type="fig"}A for a complementary analysis of SUZ12 binding.\
(B) ChIP-seq track of the *Pax6* locus with highlighted EZH2 peak.\
(C) ChIP-PCR of EZH2 (top), H3K27me3 (middle), and H3K4me3 (bottom) at selected genomic sites. Mean ± SD of three independent experiments. ^∗^p \< 0.05 between control and *Dicer*-deficient cells. EZH2 enrichment is relative to input; H3K27me3 and H3K4me3 are relative to H3.\
(D) Time-course analysis of *Dicer* deletion and loss of the miRNAs miR-291a-3p and miR-92 in *Dicer*^lox/lox^ ERt2Cre ESCs treated with carrier (EtOH) or 4-OHT. Expression of *Dicer* mRNA is shown relative to *Hprt*; expression of miRNAs is shown relative to snoRNA-135. Mean ± SD of three independent experiments. ^∗^p \< 0.05 (t test) between day 0 and the time points indicated.\
(E) EZH2 occupancy of formerly bivalent gene promoters within 8 days of ERt2Cre activation. Mean ± SD of three independent experiments. ^∗^p \< 0.05 (t test) between untreated cells (day 0) and cells treated with either EtOH or 4-OHT.](gr1){#fig1}

![*Dicer* Deletion Does Not Diminish the Expression of PcG Proteins, the Association of EZH2 with Chromatin, or Global DNA Methylation in ESCs\
(A) qRT-PCR of the PRC2 components *Ezh2*, Suz1, *Eed*, and *Jarid2*. Mean ± SD of three independent experiments. ^∗^p \< 0.05 (t test) between control and *Dicer*-deficient cells.\
(B) Immunoblots of the PRC2 components EZH2, SUZ12, EED, and JARID2 and the histone modifications H3K4me3 and H3K27me3 in control and *Dicer*-deficient ESCs. Left: representative blots. Right: densitometry readings of three independent experiments; ^∗^p \< 0.05. DICER protein is a control.\
(C) Immunoblots of cytoplasmic (Cy), nuclear soluble (Nu) and chromatin-associated (Ch) fractions of control and *Dicer*-deficient ESCs. Histone H3 identifies the chromatin fraction.\
(D) ERT2Cre *Dicer*^lox/lox^ ESCs were treated with either 4-OHT or carrier control (EtOH) and the fraction of methylated cytosine residues was followed by high-performance liquid chromatography.\
See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Accumulation of Spliced and Unspliced Transcripts and Proteins from Formerly Bivalent Genes in *Dicer*-Deficient ESCs\
(A) Gene-expression profiles of *Dicer*-deficient ESCs were examined by miReduce for 3′ UTR sequence motif enrichment.\
(B) GSEA of bivalent genes compared with miR-290 targets. FDR, false discovery rate; NES, normalized enrichment score.\
(C) GSEA results for eight sets of developmentally regulated genes. Developmentally regulated genes were separated into bivalent and non-bivalent. FDR, false discovery rate; NES, normalized enrichment score.\
(D) PCR strategy to distinguish primary (unspliced) from mature (spliced) transcripts.\
(E) qRT-PCR analysis of primary transcripts (blue bars) and mature transcripts (red bars) in response to inducible ERt2Cre activation in *Dicer*^lox/lox^ ESCs by 4-OHT. Black bars represent data for EtOH-treated control cells. Mean ± SD of three independent experiments. Expression is shown relative to *Ubc*, *Hprt*, and *Rn18s*. ^∗^p \< 0.05 (t test).\
(F) The relationship between changes in gene expression and EZH2 occupancy in Dicer-deficient ESCs. Orange shading indicates loss of EZH2 relative to increased global transcript levels (p \< 10^−8^; left). This association was strongest for bivalent genes (p \< 10^−11^; right). Gray shading indicates no significant association.\
(G) SILAC quantified 3,431 protein groups, of which 169 (4.9%) were significantly upregulated and 95 (2.8%) significantly downregulated in *Dicer*-deficient ESCs (left). Of 62 proteins encoded by bivalent genes, 14 (23%) were upregulated and 2 (3%) downregulated (right). Proteins from bivalent genes were more likely to be deregulated than proteins from non-bivalent genes (odds ratio = 4.17). The odds for up- versus downregulation were 0.56 for all proteins and 0.14 for proteins from bivalent genes (odds ratio = 3.93).\
See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![miRNAs Rescue PRC2 Binding to Formerly Bivalent Promoters in *Dicer*-Deficient ESCs\
(A) SUZ12 occupancy at transcriptional start sites of bivalent genes in control (black) and *Dicer*-deficient ESCs (red) in serum + LIF. 968 of 2,074 bivalent genes (46.7%) and 366 of 15,850 non-bivalent genes (2.3%) showed reduced SUZ12 binding in *Dicer*-deficient ESCs (p \< 10^−300^).\
(B) Control or *Dicer*-deficient ESCs were transfected with miR-294, a member of the ESC miRNA family miR-290--295. ChIP for the PRC2 core component EZH2 was done 2 days later and analyzed by real-time PCR (mean ± SE of two independent experiments).](gr4){#fig4}
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